SAN CARLOS, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- The company, founded by medical robotics entrepreneur Jian Zhang, will use these state-of-the-art facilities to pursue disruptive new medical robotics indications left unaddressed by current platforms.
“We envision a world in which next generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries,” said Zhang, Noah Medical’s founder and CEO. “These facilities are just the latest step in our journey towards that reality and they will prove critical to the development and commercialization of our first platform.”
The new Sunnyvale facility will be used to complete testing of the Galaxy System™, Noah Medical’s first to be commercialized robotic
system, a robotic-assisted platform for minimally invasive peripheral lung navigation, ahead of a planned filing for FDA clearance later in 2022. The facility will also serve as the sales and customer training site as the company plans for commercialization.
"We envision a world in which next generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries."
The new San Carlos facility, less than a mile from Noah Medical’s headquarters in San Carlos, will be used to expand Noah’s R&D capabilities and engineering team to bolster investigational capabilities and new pipeline product development.
The Society for Advanced Bronchoscopy will host a webinar to discuss the medical robotics landscape in lung navigation on March 15, 2022. Led by the Cleveland Clinic’s Dr Joseph Cicenia, University of Chicago’s Dr Kyle Hogarth and CHI Memorial’s Dr Krish Bhadra, the event will highlight Noah Medical’s new robotics technology and its potential improvement on navigational capabilities and efficiency.
To learn more about Noah Medical and the Galaxy System, or if you are interested in joining the Noah
Medical team, please visit noahmed.com.
About Noah Medical
Noah Medical is building the future of medical robotics. Our next generation robotic platforms and technologies target early diagnosis and treatment of patients across multiple indications. Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of engineers, innovators and industry leaders brings years of experience from the top robotics, medical device and healthcare companies in the world. Learn more at noahmed.com.
Media Contact:
Stephanie Hicks
PR for Noah Medical
805-295-9455
press@noahmed.com